Expanded Access Protocol of Verdiperstat in Patients With Multiple System Atrophy (MSA)

Summary

The purpose of this expanded access program is to provide access to the investigational drug verdiperstat in patients with Multiple System Atrophy (MSA). Expanded access allows patients with a serious or a life-threatening disease or condition access to an investigational drug when no satisfactory approved treatment options are available.

Timeline

Start

—

Primary completion

—

Completion

—

Drugs

Indications